Increased levels of serum soluble L-selectin in unmedicated patients with schizophrenia

Schizophrenia Research

Volumn 89, Issue 1-3, 2007, Pages 154-160

  Iwata, Yasuhide ^a   Suzuki, Katsuaki ^a   Nakamura, Kazuhiko ^a   Matsuzaki, Hideo ^a   Sekine, Yoshimoto ^a   Tsuchiya, Kenji J ^a   Sugihara, Genichi ^a   Kawai, Masayoshi ^a   Minabe, Yoshio ^a   Takei, Nori ^a,b   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Immunology; Major depression; Schizophrenia; Soluble L selectin; Unmedicated

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; L SELECTIN; PADGEM PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY;

ADULT; DEPRESSIVE DISORDER, MAJOR; E-SELECTIN; FEMALE; HUMANS; L-SELECTIN; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 33845341410     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.08.026     Document Type: Article

References (49)

1. Arbones M.L., Ord D.C., Ley K., Ratech H., Maynard-Curry C., Otten G., Capon D.J., and Tedder T.F. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1 (1994) 247-260
2. Baraczka K., Nekam K., Pozsonyi T., Jakab L., Szongoth M., and Sesztak M. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation 9 (2001) 49-54
3. Borda T., Gomez R., Berria M.I., and Sterin-Borda L. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera. Glia 45 (2004) 144-154
4. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 (1996) 60-66
5. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
6. Clark W.M., Lauten J.D., Lessov N., Woodward W., and Coull B.M. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol. 26 (1995) 213-230
7. DeLisi L.E. Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later. Schizophr. Res. 22 (1996) 1-4
8. DeLisi L.E., Weinberger D.R., Potkin S., Neckers L.M., Shiling D.J., and Wyatt R.J. Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br. J. Psychiatry 139 (1981) 513-518
9. Fessel W.J., and Hirata-Hibi M. Abnormal Leukocytes in Schizophrenia. Arch. Gen. Psychiatry 106 (1963) 601-613
10. First M., Spitzer R., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) Biometrics Research (2002), New York State Psychiatric Institute, New York
11. Ganguli R., Rabin B.S., and Belle S.H. Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry 26 (1989) 427-430
12. Gladkevich A., Kauffman H.F., and Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 559-576
13. Granert C., Raud J., Xie X., Lindquist L., and Lindbom L. Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J. Clin. Invest. 93 (1994) 929-936
14. Herbon N., Werner M., Braig C., Gohlke H., Dutsch G., Illig T., Altmuller J., Hampe J., Lantermann A., Schreiber S., Bonifacio E., Ziegler A., Schwab S., Wildenauer D., van den Boom D., Braun A., Knapp M., Reitmeir P., and Wjst M. High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics 81 (2003) 510-518
15. Ilani T., Strous R.D., and Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J. 18 (2004) 1600-1602
16. Jones A.L., Mowry B.J., Pender M.P., and Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunol. Cell Biol. 83 (2005) 9-17
17. Jun T.Y., Pae C.U., Chae J.H., Bahk W.M., Kim K.S., and Han H. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population. Psychiatry Res. 110 (2002) 19-25
18. Katila H., Cantell K., Hirvonen S., and Rimon R. Production of interferon-alpha and gamma by leukocytes from patients with schizophrenia. Schizophr. Res. 2 (1989) 361-365
19. King D.J., Cooper S.J., Earle J.A., Martin S.J., McFerran N.V., and Wisdom G.B. Serum and CSF antibody titres to seven common viruses in schizophrenic patients. Br. J. Psychiatry 147 (1985) 145-149
20. Kipnis J., Cohen H., Cardon M., Ziv Y., and Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8180-8185
21. Kuritzky A., Livni E., Munitz H., Englander T., Tyano S., Wijsenbeek H., Joshua H., and Kott E. Cell-mediated immunity to human myelin basic protein in schizophrenic patients. J. Neurol. Sci. 30 (1976) 369-373
22. Lasky L.A. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258 (1992) 964-969
23. Ley K., and Kansas G.S. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev., Immunol. 4 (2004) 325-335
24. Maes M., Bocchio Chiavetto L., Bignotti S., Battisa Tura G.J., Pioli R., Boin F., Kenis G., Bosmans E., de Jongh R., and Altamura C.A. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr. Res. 54 (2002) 281-291
25. Moises H.W., Schindler L., Leroux M., and Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatr. Scand. 72 (1985) 45-50
26. *02011. Schizophr. Res. 32 (1998) 69-71
27. Muller N., Riedel M., Hadjamu M., Schwarz M.J., Ackenheil M., and Gruber R. Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am. J. Psychiatry 156 (1999) 634-636
28. Nyland H., Naess A., and Lunde H. Lymphocyte subpopulations in peripheral blood from schizophrenic patients. Acta Psychiatr. Scand. 61 (1980) 313-318
29. Pigott R., Dillon L.P., Hemingway I.H., and Gearing A.J. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187 (1992) 584-589
30. Pollmacher T., Hinze-Selch D., and Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J. Clin. Psychopharmacol. 16 (1996) 403-409
31. Pollmacher T., Haack M., Schuld A., Kraus T., and Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J. Psychiatr. Res. 34 (2000) 369-382
32. Ponthieux A., Herbeth B., Droesch S., Haddym N., Lambert D., and Visvikis S. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 172 (2004) 299-308
33. Serafeim A., and Gordon J. The immune system gets nervous. Curr. Opin. Pharmacol. 1 (2001) 398-403
34. Schleiffenbaum B., Spertini O., and Tedder T.F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 119 (1992) 229-238
35. Schuld A., Kraus T., Haack M., Hinze-Selch D., Kuhn M., and Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr. Res. 43 (2000) 164-166
36. Schwarz M.J., Ackenheil M., Riedel M., and Muller N. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci. Lett. 253 (1998) 201-203
37. Schwarz M.J., Riedel M., Ackenheil M., and Muller N. Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biol. Psychiatry 47 (2000) 29-33
38. Tanaka S., Matsunaga H., Kimura M., Tatsumi K., Hidaka Y., Takano T., Uema T., Takeda M., and Amino N. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J. Neuroimmunol. 141 (2003) 155-164
39. Thomas A.J., Ferrier I.N., Kalaria R.N., Woodward S.A., Ballard C., Oakley A., Perry R.H., and O'Brien J.T. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am. J. Psychiatry 157 (2000) 1682-1684
40. Thomas A.J., Ferrier I.N., Kalaria R.N., Davis S., and O'Brien J.T. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br. J. Psychiatry 181 (2002) 129-134
41. Thomas A.J., Davis S., Ferrier I.N., Kalaria R.N., and O'Brien J.T. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder. Biol. Psychiatry 55 (2004) 652-655
42. Villemain F., Chatenoud L., Guillibert E., Pelicier Y., and Bach J.F. Decreased production of interleukin-2 in schizophrenia. Ann. N. Y. Acad. Sci. 496 (1987) 669-675
43. Villemain F., Chatenoud L., Galinowski A., Homo-Delarche F., Ginestet D., Loo H., Zarifian E., and Bach J.F. Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am. J. Psychiatry 146 (1989) 609-616
44. Walsh M.T., Ryan M., Hillmann A., Condren R., Kenny D., Dinan T., and Thakore J.H. Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naive, first-episode schizophrenic patients. Biol. Psychiatry 52 (2002) 874-879
45. Wagner J. Ueber die Einwirkung fieberhafter Erkrankungen auf Psychosen. Jahrb. Psychiatr. 7 (1887) 94-131
46. Wilcox C.E., Ward A.M., Evans A., Baker D., Rothlein R., and Turk J.L. Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 30 (1990) 43-51
47. Woollard K.J. Soluble bio-markers in vascular disease: much more than gauges of disease?. Clin. Exp. Pharmacol. Physiol. 32 (2005) 233-240
48. Yolken R.H., and Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 8 (1995) 131-145
49. Zhang X.Y., Zhou D.F., Zhang P.Y., Wu G.Y., Cao L.Y., and Shen Y.C. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr. Res. 57 (2002) 247-258